T. Rowe Price Associates
LONA

T. Rowe Price Associates’s LeonaBio Inc LONA Stock Holding History

T. Rowe Price Associates’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-44,566
Closed -$4.56M – 2940
2021
Q2 		$4.56M Sell
44,566
-22,730
-34% -$3.97M ﹤0.01% 1519
2021
Q1 		$12.4M Sell
67,296
-860
-1% -$190K ﹤0.01% 1361
2020
Q4 		$23.3M Sell
68,156
-20,044
-23% -$4.73M ﹤0.01% 1185
2020
Q3 		$16.3M Buy
+88,200
New +$14.7M ﹤0.01% 1201

Other funds holding LONA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

T. Rowe Price Associates's LONA Position: Q3 2021 in Review

T. Rowe Price Associates sold out of LeonaBio Inc (LONA) in Q3 2021, closing a stake of 44,566 shares — an estimated $4.56M sold.

T. Rowe Price Associates first reported a position in LONA in Q3 2020 and held it in 4 quarters. The position peaked at $23.3M in Q4 2020. 92 funds tracked by Wall St. Rank hold LONA as of Q3 2021.

  • T. Rowe Price Associates reported no remaining LeonaBio Inc position as of Q3 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 44,566 LeonaBio Inc shares in Q3 2021, an estimated $4.56M.
  • T. Rowe Price Associates first reported a position in LeonaBio Inc in Q3 2020 and held it in 4 quarters.
  • T. Rowe Price Associates's LeonaBio Inc position peaked at $23.3M in Q4 2020.
  • 92 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2021.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.